EPSTEIN-BARR-VIRUS GENOMIC SEQUENCES AND SPECIFIC ANTIBODIES IN CEREBROSPINAL-FLUID IN CHILDREN WITH NEUROLOGIC COMPLICATIONS OF ACUTE AND REACTIVATED EBV INFECTIONS
S. Imai et al., EPSTEIN-BARR-VIRUS GENOMIC SEQUENCES AND SPECIFIC ANTIBODIES IN CEREBROSPINAL-FLUID IN CHILDREN WITH NEUROLOGIC COMPLICATIONS OF ACUTE AND REACTIVATED EBV INFECTIONS, Journal of medical virology, 40(4), 1993, pp. 278-284
Four children with infectious mononucleosis (IM) and one with reactiva
ted Epstein-Barr virus (EBV) infection had concomitant central nervous
system disorders. Cerebrospinal fluid (CSF) samples from all five pat
ients contained EBV genomic sequences and EBV-specific antibodies in t
he neurologic stage, but not during convalescence. Cerebrospinal fluid
from two non-neurologic IM patients had neither EBV DNA nor EBV antib
odies. The EBV-positive CSF of the five with neurological disorders we
re aseptic in culture and all negative for other human herpesvirus DNA
s and antibodies: herpes simplex virus types 1 and 2, cytomegalovirus,
varicella-zoster virus, and human herpesvirus 6. Epstein-Barr virus D
NA and EBV antibodies were not detected in the CSF of 17 EBV-seroposit
ive patients with mumps meningitis, rubella encephalitis, unknown febr
ile convulsion, or partial epilepsy. It is suggested that EBV plays a
causal role in neurologic manifestations in patients with acute and re
activated EBV infections, through direct viral invasion and immunopath
ological reactions. (C) 1993 Wiley-Liss, Inc.